Oramed Pharmaceuticals Inc.
ORMP
$2.12
-$0.05-2.30%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 97.94M | 130.64M | 141.93M | 142.30M | 152.74M |
| Total Receivables | 611.00K | 208.00K | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 475.00K | 624.00K | 1.29M | 474.00K | 533.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 99.03M | 131.48M | 143.22M | 142.77M | 153.27M |
|
|
|||||
| Total Current Assets | 99.03M | 131.48M | 143.22M | 142.77M | 153.27M |
| Net Property, Plant & Equipment | 1.53M | 1.01M | 1.11M | 1.20M | 1.33M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.52M | 5.52M | 34.00K | 32.00K | 30.00K |
| Total Assets | 161.68M | 147.54M | 155.28M | 165.08M | 184.22M |
|
|
|||||
| Total Accounts Payable | 715.00K | 509.00K | 789.00K | 5.00M | 3.48M |
| Total Accrued Expenses | 1.13M | 1.01M | 1.48M | 35.00K | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 264.00K | 181.00K | 216.00K | 243.00K | 250.00K |
| Total Finance Division Other Current Liabilities | 1.58M | 3.79M | 3.20M | -- | -- |
| Total Other Current Liabilities | 1.58M | 3.79M | 3.20M | -- | -- |
| Total Current Liabilities | 3.69M | 5.49M | 5.69M | 5.27M | 3.73M |
|
|
|||||
| Total Current Liabilities | 3.69M | 5.49M | 5.69M | 5.27M | 3.73M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 648.00K | 120.00K | 156.00K | 186.00K | 236.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.76M | 2.03M | 4.09M | 4.10M | 4.10M |
| Total Liabilities | 8.10M | 7.65M | 9.93M | 9.56M | 8.07M |
|
|
|||||
| Common Stock & APIC | 325.50M | 325.07M | 322.88M | 322.87M | 323.87M |
| Retained Earnings | -170.97M | -184.26M | -176.62M | -166.43M | -146.81M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 154.53M | 140.81M | 146.27M | 156.44M | 177.07M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 154.53M | 140.81M | 146.27M | 156.44M | 177.07M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -946.00K | -918.00K | -918.00K | -919.00K | -911.00K |
| Total Equity | 153.58M | 139.89M | 145.35M | 155.52M | 176.15M |
|
|
|||||